Clinical Trial Update: Study to Evaluate Divigel for the Treatment of Postmenoupausal Symptoms [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Divigel (estradiol) for the treatment of postmenopausal symptoms has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause

Drugs mentioned

• DIVIGEL (Estradiol)

Snippet

Sponsor: Upsher-Smith Laboratories | Conditions: Postmenopausal Symptoms | Phase 3 | Status: COMPLETED